Cutting Edge Research Group is a clinical research site located in Oklahoma City, Oklahoma, United States 73116.
Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.
Cutting Edge Research Group has participated in 57 clinical trials with 2 currently active.
Therapeutic areas: Alzheimer's Disease, Adult Attention Deficit Hyperactivity Disorder, Major Depressive Disorder.
Sponsors: Sumitomo Pharma America, Inc., Eli Lilly and Company, Forest Laboratories.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Oklahoma · View every site in Oklahoma City
Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cutting Edge Research Group has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cutting Edge Research Group has 57 clinical trials on record, with 2 currently active. Their work covers Alzheimer's Disease, Adult Attention Deficit Hyperactivity Disorder, Major Depressive Disorder.
Cutting Edge Research Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.